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Abstract
Background
Treatment of onchocerciasis using mass ivermectin administration has reduced morbidity
and transmission throughout Africa and Central/South America. Mass drug administration is
likely to exert selection pressure on parasites, and phenotypic and genetic changes in sev-
eral Onchocerca volvulus populations from Cameroon and Ghana—exposed to more than a
decade of regular ivermectin treatment—have raised concern that sub-optimal responses to
ivermectin’s anti-fecundity effect are becoming more frequent and may spread.
Methodology/Principal findings
Pooled next generation sequencing (Pool-seq) was used to characterise genetic diversity
within and between 108 adult female worms differing in ivermectin treatment history and
response. Genome-wide analyses revealed genetic variation that significantly differentiated
good responder (GR) and sub-optimal responder (SOR) parasites. These variants were not







Citation: Doyle SR, Bourguinat C, Nana-Djeunga
HC, Kengne-Ouafo JA, Pion SDS, Bopda J, et al.
(2017) Genome-wide analysis of ivermectin
response by Onchocerca volvulus reveals that
genetic drift and soft selective sweeps contribute to
loss of drug sensitivity. PLoS Negl Trop Dis 11(7):
e0005816. https://doi.org/10.1371/journal.
pntd.0005816
Editor: Thomas R. Unnasch, University of South
Florida, UNITED STATES
Received: January 17, 2017
Accepted: July 19, 2017
Published: July 26, 2017
Copyright: © 2017 Doyle et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Relevant data is
available in the figures and supporting text.
Sequence data are archived at the European




Funding: This investigation received financial
support from UNICEF/UNDP/World Bank/World
randomly distributed but clustered in ~31 quantitative trait loci (QTLs), with little overlap in
putative QTL position and gene content between the two countries. Published candidate
ivermectin SOR genes were largely absent in these regions; QTLs differentiating GR and
SOR worms were enriched for genes in molecular pathways associated with neurotransmis-
sion, development, and stress responses. Finally, single worm genotyping demonstrated
that geographic isolation and genetic change over time (in the presence of drug exposure)
had a significantly greater role in shaping genetic diversity than the evolution of SOR.
Conclusions/Significance
This study is one of the first genome-wide association analyses in a parasitic nematode, and
provides insight into the genomics of ivermectin response and population structure of O. vol-
vulus. We argue that ivermectin response is a polygenically-determined quantitative trait
(QT) whereby identical or related molecular pathways but not necessarily individual genes
are likely to determine the extent of ivermectin response in different parasite populations.
Furthermore, we propose that genetic drift rather than genetic selection of SOR is the under-
lying driver of population differentiation, which has significant implications for the emergence
and potential spread of SOR within and between these parasite populations.
Author summary
Onchocerciasis is a human parasitic disease endemic across large areas of Sub-Saharan
Africa, where more than 99% of the estimated 100 million people globally at-risk live. The
microfilarial stage of Onchocerca volvulus causes pathologies ranging from mild itching to
visual impairment and ultimately, irreversible blindness. Mass administration of ivermec-
tin kills microfilariae and has an anti-fecundity effect on adult worms by temporarily
inhibiting the development in utero and/or release into the skin of new microfilariae,
thereby reducing morbidity and transmission. Phenotypic and genetic changes in some
parasite populations that have undergone multiple ivermectin treatments in Cameroon
and Ghana have raised concern that sub-optimal response to ivermectin’s anti-fecundity
effect may increase in frequency, reducing the impact of ivermectin-based control mea-
sures. We used next generation sequencing of small pools of parasites to define genome-
wide genetic differences between phenotypically characterised good and sub-optimal
responder parasites from Cameroon and Ghana, and identified multiple regions of the
genome that differentiated the response types. These regions were largely different
between parasites from these two countries but revealed common molecular pathways
that might be involved in determining the extent of response to ivermectin’s anti-fecun-
dity effect. These data reveal a more complex than previously described pattern of genetic
diversity among O. volvulus populations that differ in their geography and response to
ivermectin treatment.
Introduction
Onchocerca volvulus is a filarial nematode pathogen responsible for causing human onchocer-
ciasis. The infection is associated with significant morbidity, ranging from itching to severe
dermatitis and from visual impairment to blindness. This morbidity and its economic impact
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have motivated large-scale disease control programmes in the foci located in South and Cen-
tral America, Yemen and throughout Sub-Saharan Africa, where more than 99% of the global
at-risk population, estimated at 100 million people, live. Currently, onchocerciasis control is
based primarily on annual community directed treatment with the macrocyclic lactone, iver-
mectin (CDTI).
Ivermectin has a least two effects on the parasites: (i) an acute microfilaricidal effect that
results in the rapid and almost complete removal of microfilariae—the larval progeny of adult
worms—from the skin within days to weeks after treatment, and (ii) a sustained anti-fecundity
effect that results in prolonged but temporary inhibition of the release of new microfilariae
from adult female worms into the skin for approximately three to six months [1]. Although
some reports describe an increased proportion of adult dead worms following multiple iver-
mectin treatment rounds [2, 3], ivermectin is generally considered not to be a macrofilaricide
[4, 5]. Ivermectin mass treatment therefore aims to: (i) prevent, and to the extent possible
revert pathology by removing microfilariae from the skin and eyes and delaying repopulation
of these tissues with new microfilariae, and (ii) reduce transmission of O. volvulus by reducing
the number of microfilariae that can be ingested by the blackfly (Simulium) vectors. Biannual
(6-monthly) mass administration of ivermectin in hypo- and meso-endemic areas, and three-
monthly ivermectin administration in hyperendemic areas of Central and South America have
or are likely to have permanently eliminated transmission in most foci of the Americas [6–12].
Annual CDTI (expanded to biannual CDTI in some cases) and/or vector control have or are
likely to have also eliminated onchocerciasis in a number of endemic areas in Africa [13–19].
The World Health Organization Roadmap on Neglected Tropical Diseases has set the ambi-
tious target of achieving onchocerciasis elimination where feasible in Africa by 2020 [20], and
the African Programme for Onchocerciasis Control proposed expanding this goal to 80% of
the countries by 2025 [21].
In some areas of Africa, however, persistent microfilaridermia (microfilariae in the skin)
and transmission have been reported after 15–20 years of ivermectin treatment [22–33]. In
2004, O. volvulus were identified in Ghana that exhibited an ivermectin response phenotype
termed sub-optimal response (SOR). These SOR parasites were characterised by the presence
of live stretched microfilariae in the uteri of the adult worms 90 days after treatment, and were
associated with repopulation of the skin with microfilariae earlier/more extensively than
expected based on prior data. Ivermectin exposure was found not to be an explanatory factor
[29, 30]. Additional investigations have reported this phenotype in other areas in Ghana [27,
34, 35] and in Cameroon [36, 37]. Allele frequency change in a number of candidate ivermec-
tin response genes (chosen for analysis based on specific hypotheses concerning mechanisms
of resistance to the acute effects of ivermectin in O. volvulus) has also been demonstrated in
these populations when sampled before and after several rounds of ivermectin treatment [38–
44], which is consistent with population genetic changes associated with drug selection pres-
sure. While genetic selection for SOR was not demonstrated, these studies suggest that these
populations are being influenced at the genetic level by ivermectin treatment and, if these can-
didate genes mediate the phenotypic changes in ivermectin response, that SOR has a genetic
basis that may involve selection on several genes.
The reproduction biology and transmission dynamics of the parasite after ivermectin treat-
ment have been described [5, 36, 37, 45]. However, further work is required to understand: (i)
the variability in response to ivermectin that has been observed in ivermectin-naïve parasite
populations [46–48], (ii) the biological mechanism(s) by which parasites may tolerate and/or
actively mitigate the inhibitory effects of ivermectin, and (iii) the corresponding genetic archi-
tecture underpinning these biological mechanisms, the influence of genetic selection, and the
potential for SOR genotypes to be transmitted preferentially within and between parasite
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populations and thus increase in frequency. Although there has been some debate regarding
the existence of SOR to ivermectin in O. volvulus [49–53], modelling of SOR—using individ-
ual-patient data on the rate of skin repopulation by microfilariae following treatment in com-
munities with different histories of control [27, 54]–has provided support for the conclusion
that the early reappearance of microfilariae in the skin that defines SOR is most likely due to a
decreased susceptibility of the parasite to ivermectin’s anti-fecundity effect. Onchocerciasis
morbidity reduction is driven primarily by ivermectin’s microfilaricidal effect but its anti-
fecundity effect, delaying repopulation of the skin with microfilariae, also contributes. More
importantly, since both of these effects are critical for achieving interruption of parasite trans-
mission, an increase in the frequency of SORs could jeopardise onchocerciasis elimination
goals [55].
Genome-wide approaches are increasingly being employed to investigate the effects of drug
selection in human pathogens, including but not limited to, Plasmodium falciparum [56–60],
Schistosoma mansoni [61], Leishmania donovani [62] and Salmonella enterica Typhi [63]. Such
approaches have been instrumental in both confirming known and identifying novel drug
resistance-conferring loci in experimental and natural populations, and in clarifying the roles
played by selection, parasite transmission and genetic drift in drug responses. An important
feature of these studies is that they do not rely on assumptions concerning mechanisms of
resistance or candidate resistance genes. The unbiased whole-genome approach has proven
particularly useful where there is a plausible hypothesis of polygenic inheritance of a quantita-
tive trait (QT, i.e. a trait that is determined by interactions between multiple genes and the
environment, and therefore will have a continuous distribution of phenotypic values in a pop-
ulation) and when the analysis is based on natural, outbreeding field populations in a non-
model species in which the population genetic structure is unknown but may confound simple
candidate gene analysis. Given that a number of different candidate genes have been proposed
to be associated with genetic response to ivermectin treatment in O. volvulus and other para-
sitic nematode species (see reviews from Gilleard [64] and Kotze et al. [65] for discussion
of success and limitations of candidate gene approaches), the hypothesis that variation in
response by the parasite to ivermectin is a polygenic QT is both plausible and likely. Analyses
to understand SOR have been limited by several factors: O. volvulus is genetically diverse [66],
populations are likely to be genetically structured at an unknown spatial scale [67, 68], and the
parasite is a non-model outbreeding organism that is not amenable to more direct controlled
genetic crosses and quantitative trait loci (QTL) mapping methods. These challenges are fur-
ther exacerbated by limitations in providing an accurate estimate of the degree of SOR in a
given individual or population; microfilarial density in the skin determined by skin snip is an
indirect estimate of SOR and is not precise, especially when the parasite density in the skin is
low due to ivermectin treatment [69], and analysis of the reproductive status of adult worms
by embryogram is typically (but not exclusively) qualitatively measured although it is a QT.
However, recent advances in our understanding of the genome [70] and transcriptome/prote-
ome of O. volvulus [71], and more broadly, investment in publicly available helminth biology
resources such as WormBase Parasite (http://parasite.wormbase.org/, [72]), have provided the
means by which a genome-wide evaluation of ivermectin-mediated selection of drug response
in O. volvulus may now take place.
In this study, we present a genome-wide genetic analysis of drug response by comparing
genetic diversity within and between pools of adult O. volvulus from Cameroon and Ghana
that have been classified as ivermectin-naïve or little treated [NLT]), good responder (GR),
and ivermectin SOR based on host population and/or individual host treatment history,
microfilarial repopulation in the host skin after ivermectin treatment and embryogram analy-
sis of female worms. This analysis has provided new insight into the putative genetic and
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biological mechanism(s) of response by O. volvulus to ivermectin. Underlying population
structure, low susceptibility to ivermectin’s anti-fecundity effect, and potential for increase in
the frequency of such phenotypes are discussed in the context of efforts to control and elimi-
nate onchocerciasis in Africa.
Materials & methods
Ethics statement
O. volvulus samples used in this study were acquired from previously described studies con-
ducted in Cameroon [2, 36, 37] and Ghana [34, 35]. In those studies, the objectives and sched-
ule of the study were explained to all eligible individuals, and those who agreed to participate
signed a consent form and kept a copy of the latter. The data was de-identified prior to analy-
sis. Ethical clearances were obtained for the original sampling of parasites from the National
Ethics Committee of Cameroon (041/CNE/MP/06), the Cameroon Ministry of Public Health
(D30-65/NHA/MINSANTE/SG/DROS/CRC and D31/L/MSP/SG/DMPR/DAMPR/SDE/
SLE), the Ethics Committee of Noguchi Memorial Institute for Medical Research, (NMIM-
R-IRB CPN 006/01-04) and McGill University (FWA 00004545).
Sample history and phenotyping of ivermectin response
Two separate experiments using adult female worms collected from people with known indi-
vidual and/or community ivermectin treatment history and response phenotype are reported
here. Phenotypic classification of ivermectin response has been described in detail [34–37],
and for the present study was determined based on a combination of host level (skin microfi-
larial density) and female worm level (presence or absence of stretched microfilariae in utero)
characteristics (Table A in S1 Text). The number of worms collected per host and phenotypi-
cally defined by embryogram from the original studies that describe the collection of samples
are presented in Tables B-E in S1 Text.
The spatial distribution of sampling sites from the original studies is presented in Fig 1,
which shows three maps: the first presenting the relative location and distance between Cam-
eroon and Ghana in Africa, which are approximately ~1,370 km apart (to the mid-point of all
sampling sites within each country) (Fig 1A), and the second and third maps showing sam-
pling locations within Cameroon and Ghana, respectively; the sampling sites in Ghana span
approximately ~215 km (Fig 1B) and in Cameroon, ~140 km (Fig 1C).
A total of 108 adult female parasites were used in the Pool-seq analyses; a description of the
samples used, phenotypic characterisation, host and host-community ivermectin treatment
history is presented in Table F in S1 Text. Briefly, Pool-seq samples from Cameroon consisted
of 3 pools of parasites composed of: (i) ~40 drug-naïve or little treated (NLT) female worms
from the Nkam valley, (ii) 22 ivermectin GR worms, and (iii) 16 SOR worms. The Cameroon
GR and SOR parasites were collected from people living in the Mbam valley who live in com-
munities that have participated in mass ivermectin administration since 1994 (at least 13 years
prior to sampling). In addition to these treatments, these people from which parasites were col-
lected also received between 4 to 13 doses of ivermectin between 1994 and 1997 in a controlled
clinical trial [2]. Similarly, the Pool-seq samples from Ghana consisted of 3 pools of parasites
made up from: (i) 10 worms categorised as NLT, having been exposed to ivermectin 455 and
90 days prior to the time of sampling, (ii) 7 GR worms exposed to 11–16 annual doses of iver-
mectin prior to sampling, and (iii) 13 SOR worms who had been exposed to 9–16 annual doses
of ivermectin.
A total of 592 adult female worms were used in the single worm genotyping experiments; a
summary of the worms selected for Sequenom genotyping as well as the treatment history of
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the hosts and the area in which the hosts live are described in Table G in S1 Text. Parasites
from Cameroon (n = 436) are categorised into three groups of samples: (i) parasites from the
Nkam valley (NKA07; n = 140), from individuals who had been exposed to only a single iver-
mectin treatment 80 days prior to sampling, i.e., considered NLT [37], (ii) parasites from the
Fig 1. Maps of sampling sites in Ghana and Cameroon. (A) Location of Ghana and Cameroon and
distance between sampling sites. (B) and (C) sampling sites in Ghana (blue) and Cameroon (red),
respectively. Both maps have been scaled to allow comparison of distance within and between sampling
regions of each country. Numbers represent sampling locations as described in Table H in S1 Text.
https://doi.org/10.1371/journal.pntd.0005816.g001
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Mbam valley (MBM07; n = 112), from people who had been exposed to multiple rounds of
ivermectin treatment prior to sampling as described above [37], and (iii) parasites from indi-
viduals in the Mbam valley who were truly ivermectin naïve (MBM94; n = 184), sampled in
1994 prior to introduction of CDTI [2]. Response phenotype data were not collected for the
MBM94 parasites. In total, 184 ivermectin-naïve (with unknown phenotype), 225 GR, and 27
SOR parasites were genotyped. Worms from Ghana (n = 156) used for Sequenom genotyping
were sampled from 6 communities with different ivermectin exposure histories (range: 2–17
treatments; Table G in S1 Text), and were composed of 105 GR and 43 SOR parasites. An
additional 8 parasites that had been exposed to multiple annual ivermectin treatments but
whose phenotype is not available were also included.
DNA preparation and genome resequencing
DNA extraction from worms from Cameroon was performed in the REFOTDE laboratory in
Cameroon using an EZNA tissue DNA kit (Omega Bio-Tek Inc., Norcross, GA, USA). DNA
extraction from worms from Ghana was performed using the DNeasy Blood and Tissue kit
(Qiagen, Toronto, ON, Canada) at McGill University in Montreal, Canada.
The sequence data were generated from pools of worm DNA that were prepared by combin-
ing the DNA of individual worms that shared drug phenotype and geographic origin (i.e. NLT,
GR or SOR from Ghana in 3 pools; NLT, GR and SOR from Cameroon in 3 pools; S1 Table).
DNA was pooled at McGill University and sequencing was carried out at the McGill University
and Ge´nome Que´bec Innovation Centre (Montreal, Canada) across 8 Illumina GAII lanes
(Cameroon: GR and Ghana: SOR pools had sufficient DNA to allow two sequencing lanes to
increase sequencing depth). Overall, ~270-million 76-bp single-end sequences were generated,
resulting in an estimated 35.18-fold (standard deviation [SD] ± 13.30) unmapped coverage per
pool (or ~0.65–4 fold per worm if equal amounts of DNA/worm are assumed).
Read mapping and variant calling
Reads from each pool were aligned to the draft genome sequence O_volvulus_Cameroon_v3
(WormBase Parasite; [70]) using BWA-MEM [73], after which reads were realigned around
putative indels and duplicate reads (a PCR artifact that may skew variant read frequencies; see
supplement of [74] for details) were removed using GATK (v3.3–0) [75]. Approximately 70%
of the raw data were mapped, resulting in an average mapped coverage of 24.47 ± 9.07 per
pool. Three ‘pooled-sequencing’ aware variant calling approaches were used to analyse the
pooled mapping data: CRISP [76], FreeBayes (using the pooled-continuous parameter) (https://
github.com/ekg/freebayes) and PoPoolation2 [77](S2 Table). To ensure that comparisons
could be made between all sequencing pools, the raw sequence nucleotide polymorphism
(SNP) data were filtered using the following criteria: (i) the mapped read depth across a variant
site was at least 8 reads but not greater than 3 SD from the genome-wide mean read depth for
the given pool; (ii) there was no evidence of significant strand bias between forward and
reverse reads (criterion applied to minimise SNPs caused by alignment artifacts, see supple-
ment of [74] for details); (iii) variants were bi-allelic SNPs, and (iv) variants associated with
reads mapped to Wolbachia or mtDNA sequences were removed. The intersection of these
three approaches post-filtering yielded 248,102 shared variable sites relative to the reference
sequence.
Genome-wide analyses of differentiation
To perform the genome-wide analyses of genetic differentiation of the sequencing pools,
we used only variants found in the intersection of the three Pool-seq-aware SNP calling
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approaches described above for all following analyses. Given the statistical uncertainty associ-
ated with interpreting low coverage read frequencies for any given SNP locus, we focused on
analyses of relative genetic diversity between groups by calculating FST in 10-kb sliding win-
dows across the genome, and FST of gene features based on the O_volvulus_Cameroon_v3
genome build from WormBase Parasite (http://parasite.wormbase.org/; onchocerca_volvulus.
PRJEB513.WBPS5.annotations). FST values for each defined genomic window for both the
genome-wide and genic datasets (10 kb or whole gene, respectively) were generated using
PoPoolation2 [77] fst-sliding.pl with the following parameters:—min-count 2,—min-coverage
8,—max-coverage 2%, with corresponding individual haploid pool sizes specified). Analyses of
significance between different groups for individual SNPs were performed using Fisher’s exact
tests (PoPoolation2 fisher-test.pl) to explore shared variants present in both Ghana and Camer-
oon. Analyses of variant frequency were performed using the variant read frequency generated
from the CRISP output.
One of the primary aims of this analysis was to define regions of the genome that differed
significantly between phenotypic classes in each country, on the assumption that such region
(s) of genetic differentiation would contain a locus or loci that contributed to the phenotypic
difference between the pools analysed. We defined a genomic location as significant if it con-
sisted of two or more adjacent 10-kb windows (from the FST sliding window analysis) in which
the GR vs. SOR FST values were greater than 3 SDs from the genome-wide mean FST within a
50-kb window (unless otherwise stated).
Single worm genotyping by Sequenom MassARRAY
A subset of genome-wide SNPs (160 in total) were chosen to explore ivermectin association
and population structure further by Sequenom genotyping of individual adult female worms
phenotyped for ivermectin response. DNA from 592 individual female worms (described in
Table G in S1 Text) was prepared for Sequenom MassARRAY genotyping (Sequenom, Inc.,
San Diego, CA, USA)[78]. Due to the DNA quantity requirements for Sequenom analysis (600
ng per sample), many individual worm DNA samples (401 of 436 samples from Cameroon, 96
of 156 samples from Ghana) required whole genome amplification to increase the DNA con-
centration. This was performed using the REPLI-g screening kit (Qiagen, Toronto, ON, Can-
ada). DNA concentrations of all samples were quantified using Quant-iT Pico Green dsDNA
Assay Kit (Life Technologies Inc, ON, Canada), before sending to the McGill University and
Ge´nome Que´bec Innovation Centre for genotyping.
Population- and ivermectin association analyses of individually-
genotyped worms
Sequenom data were analysed using PLINK [79]. Raw data were filtered based on allele fre-
quency (loci with<0.05 minor allele frequency were removed; PLINK—maf 0.05), genotype
quality (samples with<80% assay success rate were removed: PLINK—mind 0.2; SNPs with
<80% genotype call frequency were removed: PLINK—geno 0.2). Filtered Sequenom data
(130 SNPs in 446 samples [Table G in S1 Text; sample numbers in analysis are indicated in
parentheses]; 81.25% of total SNPs and 75.33% of total samples, respectively) were analysed by
multidimensional scaling to assess geographic vs. phenotypic influence on genetic diversity.
Hardy-Weinberg equilibrium (HWE) was analysed using the same filtering conditions
described above (PLINK—hardy), using the—keep function to analyse samples from each
country separately. Discriminant analysis of principal components (DAPC) and population
assignment based on membership probabilities were performed using the R package adegenet
[80].
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Accession numbers
Sequence data are archived at the European Nucleotide Archive (ENA) under the study acces-
sion PRJEB17785.
Results and discussion
A genome-wide approach was used to detect genetic signatures associated with the sub-opti-
mal responder (SOR) phenotype of O. volvulus when exposed to ivermectin. The criteria
used to select good responder (GR) and SOR parasites for analysis were based on (deemed to
be related) host and parasite characteristics [29, 30] (Table A in S1 Text): (i) at the host level,
the number of microfilariae in the skin determined by diagnostic skin snips is >7% of the
pre-treatment value in SOR around 3 months post treatment (80 or 90 days for the samples
from Cameroon and Ghana, respectively), whereas microfilariae are largely undetectable in
GR at this time, and (ii) at the parasite level, SOR macrofilariae contain stretched microfilar-
iae (ready to be released) in utero around 3 months post treatment (80 or 90 days for the sam-
ples from Cameroon and Ghana, respectively), as determined by embryogram, while GR do
not. An SOR parasite, therefore, causes earlier repopulation of the skin with microfilariae
than a GR parasite due to an earlier resumption of microfilarial release after temporary inhi-
bition of fecundity. Samples were chosen from parasite cohorts obtained from Cameroon [2,
36, 37] and Ghana [34, 35]. An analysis of these sample cohorts (Tables B-E in S1 Text)
revealed that both GR and SOR adult O. volvulus were simultaneously present in an individ-
ual host, supporting prior conclusions that the extent of response is determined by parasite
characteristics, rather than insufficient ivermectin exposure [30]. The ratio of GR:SOR adult
O. volvulus is not necessarily representative of all adult worms in a host since only a fraction
of O. volvulus in a host are present in palpable nodules amenable to excision [46, 81, 82], and
those parasites in deep non-palpable nodules or worm bundles can contribute to the skin
microfilarial levels measured, i.e. the host-level response classification. This is evident in the
data from the study conducted in Ghana in which all palpable nodules had been excised and
phenotyped (Fig A in S1 Text); some hosts classified as SOR contained only female worms
with a GR phenotype, whereas from a few hosts classified as GR, only SOR adult worms were
in palpable nodules.
Genome resequencing of pooled, phenotyped O. volvulus from Ghana
and Cameroon
To investigate the genetic differences between GR and SOR adult O. volvulus, whole genome
sequencing was performed on pools of adult female worms from Cameroon and Ghana that
were classified as naïve or little treated [NTL], or multiply treated GR and SOR groups based
on the prior ivermectin exposure of the hosts and/or community from whom they were col-
lected, and the host and parasite level response to ivermectin as described above (see Table F
in S1 Text for characteristics of the worm pools). We identified 248,102 variable positions that
were shared among all groups and passed our stringent filtering criteria (S2 Table), at an aver-
age marker density of 1 variant per ~389-bp (of the 96,457,494-bp nuclear genome). This rep-
resented only 32.7% of the total putative variants identified using the three variant analysis
pipelines, primarily as a result of the relatively relaxed variant calling parameters of PoPoola-
tion2 (S2 Table; 34.4% of SNPs called by PoPoolation2 were unique to this tool under the
conditions used compared to 2.6% and 6.2% of unique SNPs called by CRISP and FreeBayes,
respectively) and in part due to the stochastic variation in allele detection in low sequence cov-
erage Pool-seq data.
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Pool-seq has been used to estimate population genetic diversity in a number of different
species [77, 83–86] on the assumption that individual read frequencies at a variant site are a
proxy for allele frequency. This approach relies on sampling sufficient reads at any given posi-
tion to be confident in detecting the diversity present; the more reads sequenced at a position,
the closer the read frequency is to the true allele frequency. Considering that approximately
24.47-fold mapped coverage per pool (range: 0.53–3.05-fold coverage per worm) was obtained
overall, it is unlikely that any of the pools was sequenced at sufficient depth to sample each
genome present. Analyses of variation in read frequency between pools at low sequence
coverage for any given nucleotide variant should, therefore, be treated with caution as they are
confounded by significant statistical variation in coverage per genome [87], and likely under-
powered for detecting true allele frequency differentiation [88]. In addition to strict filtering of
the variants (e.g. to remove putative variant sites that were not detected by all three variant
callers in all pools), we have attempted to account for this uncertainty by focusing on genetic
variation calculated from multiple SNPs, either in sliding windows across the genome or on
whole genes, rather than on individual nucleotide variants, an approach which has been dem-
onstrated to improve significantly the accuracy of estimates of diversity at low coverage [89]. A
significant finding of this study was that genetic variation that differentiated GR and SOR
pools was not randomly distributed but was strongly clustered in multiple discrete regions of
genome. This observation establishes clearly, for the first time, both the genetic architecture
and likely mode of selection of ivermectin response in O. volvulus, which is described in detail
below.
Genome-wide genetic differentiation between ivermectin response
phenotypes
The two important questions with respect to the evolution of SOR are (i) which locus or loci
are under selection, and (ii) whether the same loci are under selection in different populations,
i.e., whether variation that differentiated SOR and GR worms in Ghana also differentiated
SOR and GR worms in Cameroon. Shared variation between diverse geographic regions that
differentiated SOR from GR would provide candidate markers that may predict ivermectin
response in previously uncharacterised populations, and thus form the basis for the develop-
ment of a ubiquitously applicable tool for monitoring the relative frequency of SOR and GR
before and during CDTI. Pairwise analyses of individual SNPs (p-values from Fisher’s exact
test; Fig 2A) and FST calculated from 10-kb windows (Fig 2B) derived from the Pool-seq analy-
sis both revealed a higher degree of differentiation between SOR and GR pools from Camer-
oon than between SOR and GR from Ghana, i.e., there were more loci or regions above
significance thresholds in the Cameroonian pools. This difference is likely to be due to the
unequal sample size between the two countries (Cameroon = 22 GR and 16 SOR worms;
Ghana = 7 GR and 13 SOR worms); a greater proportion of total genetic diversity will be pres-
ent in the Cameroon dataset as more worms are present, however, at the same time, the
sequencing depth per Cameroon genome is lower than for the Ghana samples, and hence, will
increase the stochastic variation in the Cameroon variant frequency. Although many single
SNP loci from each country showed significant variation between SOR and GR pools when
each country was analysed independently, only a single intergenic SNP (OM1b_7179218) was
significantly different between pools and common to both countries (Fig 2A; red dot) after a
Bonferroni genome-wide correction (Fig 2A; dashed lines) was applied. Furthermore, only six
10-kb regions that showed significant deviation above a genome-wide mean FST threshold of
+3 SDs between GR and SOR were shared between Ghana and Cameroon (Fig 2B; dashed
lines; red dots; S3 Table). Relaxing the threshold to +2 SDs yielded 22 additional 10-kb regions
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that were able differentiate GR from SOR and were shared between countries (Fig 2B, orange
dots; S3 Table). A total of 28 FST windows at> +2 SDs is only marginally more than the
number of windows that is expected to exceed +2 SDs by chance alone (0.052 x 9893 10-kb
loci = 24.73), and may in fact be inflated considering: (i) 11 of the 28 10-kb windows were
immediately adjacent to at least one other 10-kb window in the genome and, therefore, are
unlikely to all be segregating independently, and (ii) four of these 28 10-kb windows contained
sequences associated with Pao retrotransposon peptidase- and integrase-related proteins and a
further two windows contained ribosomal subunits (S3 Table). Given the multi-copy nature of
these sequences, the high FST value for these 6 windows is likely to be a technical error associ-
ated with poor read mapping of multicopy sequences rather than true biological differentia-
tion. These results suggest that, even at a reduced genome-wide level of significance threshold
Fig 2. Analysis of shared genetic variation that differentiates ivermectin good responder (GR) from
sub-optimally responding (SOR) Onchocerca volvulus adult worms in both the Cameroon and Ghana
population samples. Genetic differentiation was measured using individual single nucleotide polymorphisms
(SNPs) (Fisher’s exact test; A) or 10-kb windows (FST; B). Dotted lines represent statistical cutoff applying the
Bonferroni correction for SNPs and genome-wide mean FST + 3 standard deviations (SDs) (Cam: 0.355; Gha:
0.255) for 10-kb windows. Red dots highlight differentiation above genome-wide cutoffs that is shared by both
groups. Orange dots represent additional shared differentiation at 2 SDs in the FST analysis (B). Manhattan
plots of genome-wide FST describing spatial genetic differentiation between GR and SOR pools for both
Cameroon (C) and Ghana (D). Each point represents FST calculated for a non-overlapping 10-kb window.
Plots are coloured to differentiate the main genomic scaffolds from unplaced scaffolds and contigs. Dotted
lines represent genome-wide mean FST + 3 SDs (dark grey; Cam: 0.355; Gha: 0.255) and FST + 5 SDs (light
grey; Cam: 0.508; Gha: 0.351).
https://doi.org/10.1371/journal.pntd.0005816.g002
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(i.e., > + 2 SDs), little genetic variation that discriminated GR from SOR parasites was shared
between the two countries.
To investigate the distribution of genome-wide genetic variation between ivermectin
response groups, we analysed the relative positions of SOR vs. GR 10 kb FST windows > +3 SD
in the O. volvulus genome. A striking finding was that the 10-kb regions that provided the
most genetic differentiation between SOR and GR were not randomly distributed but were
found in discrete clusters (Fig 2C & 2D); we interpret these clusters of significantly differenti-
ated 10-kb windows (defined as 2 or more adjacent 10-kb windows within a 50-kb window
> +3 SDs from the genome-wide mean FST calculated separately for each country) as putative
quantitative trait loci (QTLs). These QTLs are composed of a variable number of 10-kb win-
dows and contain multiple genes. In total, 18 putative QTLs that mapped to well-assembled
regions of the genome were found in the Cameroon data (Fig 2C; mean QTL size of 66,389
bp ± 55,157 bp SD) and 14 putative QTLs in the Ghana data (Fig 2D; mean size of 102,143
bp ± 95,690 bp SD), representing 1.2% and 1.5% of the ~96.4 Mb nuclear genome, respectively
(S4 Table).
These data provide strong evidence that (i) the SOR phenotype is a polygenic quantitative
trait (QT), (ii) the Ghana and Cameroon SOR populations were genetically distinct as indi-
cated by the apparent lack of concordance between Ghana and Cameroon SOR QTLs, and (iii)
the different putative QTLs may be under selection in these two geographically separated para-
site populations as indicated by only a single putative QTL common to Ghana and Cameroon
SOR worms. These observations suggest that soft (rather than hard) selection on pre-treatment
genetic variation in the two parasite populations has acted on different loci in each country,
and in turn, resulted in a different signature of selection in each country (for principles of hard
vs. soft selection, see Section 2 in S1 Text, including characteristics of soft and hard selection
[Fig. B and Table J in S1 Text], and a simple multilocus QTL model to illustrate the genetic
outcome of soft selection [Table I in S1 Text]). Soft selection also implies that it may therefore
be difficult to separate differences between Ghana and Cameroon SOR populations that are
the result of selection from those that are the result of genetic drift. However, the pattern of
genetic variation within each country (see below) is consistent with the conclusion that the dif-
ferentiation between GR and SOR worms (within the same country) is associated with pheno-
typic differences in ivermectin response.
Analysis of between-country genetic variation, and genetic diversity
between responder phenotypes and drug-naïve worms
To test more explicitly for population structure between the two countries and thus, better
understand the extent to which the standing genetic variation (see Section 2 of S1 Text) in
these populations may have been shaped by the combination of selection and genetic drift, we
analysed genetic differentiation between and within the two countries across the three treat-
ment history/response categories (i.e. NLT, GR and SOR). Correlation of genome-wide allele
frequencies within and between countries demonstrated significantly higher shared variation
within each country than between countries, where allele frequency correlation was low (Fig
3A). This supports the conclusion that there is significant genetic differentiation between the
parasite populations in the two countries, and that any genetic signal associated with SOR that
might have been common to both countries would likely to be masked by the presence of sig-
nificant population genetic structure. Somewhat unexpectedly, a comparison of allele fre-
quency correlations between response groups within each country suggested that, for both
Cameroon and Ghana, the NLT worms were genetically more similar to the SOR worms than
to the GR worms (Fig 3A). A direct pairwise comparison of the three treatment history/
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Fig 3. Analysis of genetic diversity between ivermectin responder phenotypes and drug-naïve (NTL) worms. (A) Spearman rank
correlation analysis of variant read frequencies from 248,102 SNPs. Values within each square represent the correlation coefficient for each
pairwise analysis. (B) Degree of shared variation determined by pairwise comparisons of FST between treatment and response groups,
summarised from 9,893 10-kb windows throughout the genome. FST distributions were compared statistically using a two-sample
Kolmogorov-Smirnov [KS] test. (C) Variant read frequency spectrum from treatment and response subgroups for Cameroon and Ghana.
The variant read frequency was calculated at each of the 248,102 SNP positions, from which the proportion of total variants in 0.05
frequency bins is presented. (D) Analysis of invariant loci per group as a proportion of the total number of variants observed, defined as
variant read frequencies < 0.05 (blue) and > 0.95 (red).
https://doi.org/10.1371/journal.pntd.0005816.g003
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response categories within each country using genome-averaged FST values (calculated from
9,893 10-kb windows) was consistent with this observation: NLT vs. SOR FST genomic medi-
ans were significantly smaller (Cameroon: 0.059; Ghana: 0.068) than either NLT vs. GR medi-
ans (Cameroon: median = 0.095; two-sample Kolmogorov-Smirnov [KS] test: D = 0.0438,
p< 0.001; Ghana: median = 0.110; KS D = 0.575, p< 0.001), or GR vs. SOR medians
(Cameroon: median = 0.112, KS D = 0.544, p< 0.001; Ghana: median = 0.104, KS D = 0.495,
p< 0.001) (Fig 3B). The closer relationship between NLT and SOR than between NLT and GR
is particularly surprising for Cameroon when one considers that the NLT and GR/SOR popu-
lations are from geographically distinct areas, i.e., the sampling sites within the Nkam and
Mbam valleys were>100 km apart in two distinct river basins separated by the Western High
Plateau of Cameroon (see Fig 1 for map of sampling sites). However, seasonal dispersal of the
local vector species, Simulium squamosum, has been observed in Cameroon over greater dis-
tances than the distance between the two sampling regions here [90], and therefore, further
investigation on the extent of seasonal transmission between the two river basins is required.
Although these pairwise comparisons demonstrate differential degrees of genetic relatedness
between the phenotypically defined groups within each country, the degree of genetic differen-
tiation, i.e., median FST range between 0.059–0.112 in Cameroon and 0.068–0.110 in Ghana, is
moderate and likely to reflect some, but not complete, restriction on gene flow between groups
due to differential transmission. Given that GR parasites in both countries show significantly
greater differentiation to both SOR and NLT groups, these data are consistent with greater
transmission restriction of GR parasites than SOR parasites.
The observation of higher genetic similarity between the NLT and SOR populations sup-
ports the hypothesis of soft selection for SOR because it suggests that selection for SOR from
an ivermectin-naïve population led to relatively little genome-wide reduction in genetic varia-
tion. A characteristic prediction of soft as opposed to hard selection (see Section 2 of S1 Text)
is that unlike hard selection, soft selection should not markedly reduce the genome-wide
genetic diversity following selection. Since the SOR phenotype is associated with an early
resumption of reproduction and, consequently, with the early availability of SOR offspring in
the skin for vectors to ingest, ivermectin treatment is likely to interrupt the transmission of
SOR genotypes for only a relatively short period of time between CDTI rounds compared to
GR transmission interruption. If SOR alleles are already present on many different genetic
backgrounds in the NLT starting population, this continued transmission of SOR genotypes
under drug treatment will maintain genetic diversity in the SOR population, which is consis-
tent with what we have observed in the present study.
The strong, genome-wide, between-country genetic differentiation in the NLT populations
implies that the standing genetic variation from which SOR is selected varies significantly
between Ghana and Cameroon, and explains why the genetic outcome of selection of SOR dif-
fers between countries (as shown by the lack of concordance between Ghana SOR and Camer-
oon SOR populations). The presence of strong population structure between Cameroon and
Ghana is not unexpected. The O. volvulus lifecycle is characterised by significant population
(and mostly density-dependent) bottlenecks at each transmission event: only a miniscule pro-
portion of microfilariae under the skin of human hosts are ingested by blackflies, and very few
resulting infective larvae are subsequently transmitted to humans and establish as adult worms
[91]. Repeated bottlenecks increase the severity of genetic drift by strongly enhancing the sto-
chastic processes that generate genetic diversity between populations, independent of drug
treatment, suggesting that genetic drift had created genetic differentiation between different
parasite populations before initiation of CDTI, and that subsequent soft selection of SOR
genotypes from these genetically distinct populations has led to SOR populations that are
genetically distinct despite their phenotypic similarity. In contrast, CDTI interrupts
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transmission of GR genotypes for a longer period of time. If this reduces the proportion of GR
worms that contributes to the next generation, it will lead to a loss of genetic diversity and an
increase in genetic drift in subsequent GR populations relative to both the population before
CDTI was initiated and the SOR population. This expectation is consistent with genetic change
described in single-gene studies following treatment over time in O. volvulus [38–44].
To further investigate the impact of soft selection on GR and SOR genetic diversity, we esti-
mated the genetic diversity within the pools of GR and SOR worms from each country in two
complementary ways: (i) by calculating the variant read spectrum per pool (as a proxy for the
allele frequency spectrum, Fig 3C), and (ii) from the relative proportion of invariant SNP loci,
which we have defined as SNP loci with variant read frequencies<0.05 or > 0.95 (Fig 3D).
These complementary analyses provide insight into the degree of genetic variation present
within each drug response parasite pool, and will detect loss of genetic diversity. The pool of
GR worms from both countries were less diverse and had a greater proportion of invariant loci
than the pools of SOR and NLT parasites, particularly in Cameroon, whereas the SOR and
NLT parasites had similar levels of genetic diversity.
Comparisons of genetic diversity between the pools of NLT, GR and SOR parasites there-
fore support our hypothesis of soft selection for SOR, and explain both the relatively subtle sig-
nature of selection in the SOR parasites and the strong population structure observed between
the SOR parasites from Cameroon and Ghana.
Characterisation of molecular pathways identified from genes within
QTLs that differentiate ivermectin response
In light of evidence suggesting that genetically separated parasite populations contain different
standing genetic variation before the introduction of CDTI, and thus that ivermectin-mediated
soft selection may produce different genetic outcomes in SOR parasites between Cameroon
and Ghana, it was of interest to compare genes within the putative QTLs identified in the SOR
worms from Ghana and Cameroon. While we identified only a single putative QTL that was
common to the SOR parasites from the two countries, the putative QTLs from each country
contained genes encoding proteins that act in a limited number of molecular pathways. This
implies that although different genes may be under selection in Ghana and Cameroon, there
may be a common biological mechanism that confers SOR in both countries (see Table 1 for a
summary of genes with common functional characteristics and/or shared pathways identified
in the QTLs, and S5 Table for characterisation of all genes within each QTL).
The most prominent group of genes under the putative QTLs defined above were associated
with neurotransmission (17 genes in 14 QTLs), which was encouraging considering that the
primary target of ivermectin is a ligand-gated channel at neuromuscular junctions [92]. Given
that the duration of the anti-fecundity effect of ivermectin distinguishes the GR and SOR phe-
notypes, the fact that nine of those genes (in eight QTLs) were associated with acetylcholine
signalling is of particular interest because acetylcholine signalling plays an important role in
the regulation of egg laying in Caenorhabditis elegans, and therefore, may be relevant to iver-
mectin’s anti-fecundity effect in O. volvulus.
These genes include a number of ion channels (Ovo-acc-1, Ovo-lgc-46,Ovo-lgc-47), and
components of acetylcholine synthesis (Ovo-cha-1), transport (Ovo-unc-17, Ovo-aex-3), and
regulation (Ovo-pha-2, Ovo-snb-1, Ovo-emc-6,Ovo-nrfl-1). The unc-17 and cha-1 mutants in C.
elegans exhibit hyperactive egg-laying phenotypes associated with defects in laying inhibition
[93, 94], and acetylcholine activation of egg laying in C. elegans is regulated by neuropeptides,
serotonin and glutamate [95]. Furthermore, acetylcholine receptors have recently been
proposed to be involved in the development of the nervous system during embryo- and
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spermatogenesis in the filarial parasite Brugia malayi [96]. In addition, two recent studies dem-
onstrated inhibition of L-AChR receptors in C. elegans by ivermectin [97] and antagonistic
effects of abamectin on nicotinic acetylcholine receptors [98], implying that under some cir-
cumstances ivermectin may act directly on acetylcholine signalling. We therefore hypothesise
that modification of neurotransmission in general, and acetylcholine signalling pathways in
particular, may contribute to ivermectin SOR and reflects an overall adjustment in neuromus-
cular signaling that mitigates the effects of ivermectin. This variation may also contribute to
the changes in fecundity that have been associated with the SOR phenotype [99] by changing
the way in which neurotransmission might influence the release of microfilariae in an analo-
gous fashion to neuronal control of egg laying in C. elegans. Given the enrichment of neuronal
genes that may play a role in regulating reproduction, it is of interest to note that the single
QTL that is shared between Cameroon and Ghana SOR parasites includes Ovo-aex-3, a neuro-
nal protein and regulator of synaptic transmission. This gene may be of particular interest
because the C. elegans orthologue plays a role in reproduction and also in regulation of pharyn-
geal pumping [80] (a phenotype for which alleles have been associated with reduced sensitivity
to ivermectin in C. elegans). In addition, this QTL also includes Ovo-stg-1, which may be of
interest due to its putative chaperone-like role in regulating ionotropic glutamate receptor
(iGluR) function and a hypothesised role in protecting neurons from excitotoxicity or inap-
propriate depolarisation in C. elegans [81].
Nine putative QTLs contained genes associated with stress responses, including heat-shock
proteins (Ovo-hsp-17,Ovo-hsb-1), and genes required for the synthesis (Ovo-acs-16,Ovo-fat-4,
Ovo-spl-1,Ovo-tat-2), regulation and storage (Ovo-obr-2, Ovo-sms-1,Ovo-math-46, Ovo-mtd-
15, Ovo-cuc-1) of lipids. Variation in gene expression in lipid metabolism-encoding genes fol-
lowing ivermectin treatment in C. elegans has been described [100], which was interpreted as a
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metabolic adaptation to starvation due to ivermectin inhibition of pharyngeal pumping but
may also be a more general indicator of organismal stress. Genes associated in general with
stress responses, including lipid metabolism, are often reported in genome-wide analyses for
loci under drug selection pressure [56].
Other genes under the putative QTLs include those acting in pathways involved in develop-
mental processes, including muscle assembly and myosin organisation (three QTLs contained
6 loci; Ovo-mup-4, Ovo-mua-3, Ovo-mlc-5,Ovo-unc-82, Ovo-nmy-1, Ovo-sca-1), and germline
and larval development signals associated with notch signaling (three QTLs), specifically with
the suppression (Ovo-bre-5) or cleavage (Ovo-pen-2,Ovo- crb-1) of the LIN-12 receptor. The
relevance, if any, of these developmental genes to ivermectin response is not known.
This list of genes that fall under the QTLs leads to a hypothesis of SOR as tolerance to iver-
mectin’s anti-fecundity effect brought about by a re-tuning of neuronal function in combina-
tion with a stress response. We acknowledge the tentative nature of this hypothesis given: (i)
the limitations in the resolving power of genetic-association analysis based on modest
sequencing depth of a limited number of pooled samples, that could result in both false-posi-
tives and a lack of power to detect rare variation, i.e., false-negatives, (ii) only a single compari-
son between GR and SOR parasites was made from each country, (iii) the inability to carry out
more specific analysis of coding sequence variation imposed by limited genetic resolution, (iv)
the large number of predicted genes that lack functional annotation in the O. volvulus genome
(~67.4% of the coding sequences within the QTLs are unannotated or hypothetical), and (v)
the methods available for phenotype classification, which has limited sensitivity for the deter-
mination of the presence and extent of microfilarial density in the skin [69] and is qualitative
with respect to the presence or absence of live stretched microfilariae in utero, which in turn
decreases the power of genetic association. However, the polygenic signature associated with
ivermectin response is consistent with the outcome of two genome-wide scans examining iver-
mectin resistance in Dirofilaria immitis [101], and Teladorsagia circumcincta [102], both of
which support the hypothesis that ivermectin response is a quantitative, multigenic trait.
Moreover, the enrichment of neurotransmission and stress response genes in the QTLs that
differentiate GR and SOR parasites in two geographically independent populations is striking,
and does provide support for our hypothesis of a polygenic QT characterised by earlier recov-
ery from the acute effects of ivermectin on fecundity.
If correct, this hypothesis implies that the SOR adult worms remain sensitive to the acute
effects of ivermectin on fecundity but recover more quickly than GR worms. Early recovery
from the acute effect of ivermectin on fecundity does not require a mechanism that is specific
to the mode of action of that acute effect, so a polygenic retuning or buffering of the neuronal
regulation of reproduction that leads to earlier recovery of fertility is biologically plausible. It
may also explain why our analyses have failed to validate candidate genes that would protect
worms against ivermectin’s acute effects (see below).
Analysis of candidate ivermectin-resistance genes
Given the extensive literature focused on candidate genes (i.e. genes chosen for analysis based
on specific hypotheses concerning mechanisms of resistance to the acute effects of ivermectin
in O. volvulus) from C. elegans and other helminths for which ivermectin is used as an anthel-
mintic, and the apparent absence of these genes from the QTLs described here, it was impor-
tant to investigate these genes, which included glutamate-gated chloride channels (Ovo-avr-14,
Ovo-glc-2,Ovo-avr-15, Ovo-glc-4), p-glycoproteins (Ovo-pgp-1,Ovo-pgp-10,Ovo-pgp-11,Ovo-
plp-1), ABC transporters (Ovo-abcf-1, Ovo-abcf-2, Ovo-abcf-3) and other candidates (Ovo-ben-
1 [beta tubulin], Ovo-lgc-37,Ovo-mrp-7,Ovo-dyf-7).Ovo-abcf-1 was the only candidate gene
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found in a QTL. For the majority of the other genes (including Ovo-pgp-11 for which variation
in allele frequency in a pgp orthologue of the closely related filarial parasite D. immitis has
been demonstrated to correlate with loss of ivermectin efficacy [103]), no significant SOR vs.
GR FST differences were observed (S6 Table). Ovo-abcf-1 (in QTL-5), Ovo-abce-1, Ovo-dyf-7,
and Ovo-pgp-10did show moderate levels of differentiation, but none were statistically signifi-
cant. Given that our data suggest that parasite populations are structured and that alleles asso-
ciated with ivermectin response may vary between populations, we cannot exclude that these
loci contribute to variability in ivermectin susceptibility in other O. volvulus populations. How-
ever, considering the evidence of multiple putative QTLs and strong geographical population
structure, it is possible that single candidate gene comparisons may have been confounded by
population structure and the polygenic nature of the trait. We conclude that there was no evi-
dence of significant genetic differentiation in these candidate genes between the SOR and GR
populations compared here.
Three of the 31 putative QTLs did contain genes associated with neuronal function that
have been linked previously to ivermectin sensitivity in C. elegans (Table 1; S5 Table): Ovo-
unc-44, a likely orthologue of a C. elegans gene that influences ivermectin sensitivity and is
involved in neuronal development [104], Ovo-inx-5, which in C. elegans encodes an innexin
gap junction protein that is associated with the pharyngeal motor neurons and is related to
unc-9 (a known ivermectin-resistance allele [105]), and Ovo-klp-11, a kinesin motor protein
found in the cilia of chemosensory neurons in C. elegans, which has significant homology to,
and is a likely binding partner of, Ovo-osm-3, alleles of which have been described to decrease
sensitivity to ivermectin in C. elegans [104].
Geographic and genetic distribution of ivermectin susceptibility
Given the importance of the distinction between population structure as a result of genetic
drift and phenotypic differentiation as a result of selection for SOR, we sought to investigate
ivermectin response genetics in a larger cohort of individual female worms (most having been
characterised for their ivermectin response phenotypes via embryograms [34–37]; Table G in
S1 Text) by genotyping individual worms at 160 SNP loci by Sequenom (S7 Table). The loci
were chosen based on the original Pool-seq analyses to determine the degree of genetic associa-
tion with response phenotype, and to characterise genetic structure within these populations.
Multidimensional scaling analysis (MDS) was used to interrogate the Sequenom genotyping
data from 446 female worms at 130 SNPs that passed filtering criteria. Three aspects of the
data are highlighted (in different panels, Fig 4): (i) between-country population structure, (ii)
within-country population structure, and (iii) differentiation between response phenotypes.
Consistent with the Pool-Seq analysis, we observed clear genetic differentiation between
Sequenom-genotyped worms from Ghana and worms from Cameroon: there were very few
[blue] Ghanaian worms mixed with the [red] Cameroon worms (Fig 4A), regardless of
response phenotype. Analysis of worms by their community of origin to allow within- as well
as between-country comparisons did not reveal any internal genetic structure in the Ghanaian
populations or between the Cameroonian NKA07 and MBM07 [pink and red, respectively]
populations (Fig 4B).
Interpretation of the Cameroon data is more complex than for Ghana due to the likely exis-
tence of underlying population structure that is both temporal and spatial in origin: within
Cameroon, MBM94 [light orange] was genetically distinct from both NKA07 and MBM07
populations but NKA07 and MBM07 were indistinguishable. MBM94 and MBM07 are two
samples drawn from the same geographical location in Cameroon (the Mbam valley) at differ-
ent times: MBM94 was sampled in 1994 before ivermectin distribution began, and is drug-
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Fig 4. Analysis of genetic differentiation among 446 O. volvulus female worms from Ghana and
Cameroon individually genotyped at 130 loci distributed throughout the genome. Multi-dimensional
scaling analysis was used to determine the relative genetic similarity between worms. Plots contain the same
data, but have been presented to emphasise the degree of genetic differences between countries (A), sampling
communities within each country (B), and their treatment exposure and phenotypic response to ivermectin if
known (C). Ghanaian sampling sites: Asubende (ASU), Begbomdo (BEG), Jagbenbendo (JAG), Kyingakrom
(KYG), New Longoro (NLG), and Wiae (WIA). Cameroonian sampling sites: Nkam valley (NKA07), Mbam valley
sampled in 1994 (MBM94) before introduction of annual CDTI in 1994 and sampled in 2007 (MBM07).
https://doi.org/10.1371/journal.pntd.0005816.g004
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naïve, whereas MBM07 was sampled in the Mbam valley after 13 years of annual CDTI and
contains approximately 16% SOR and 84% GR parasites (n = 112). Given that MBM07 is still
largely GR, we interpret this signal of strong population differentiation as the result of genetic
drift from MBM94, i.e., of largely stochastic (rather than deterministic, i.e., selection) genetic
change likely brought about by multiple population bottlenecks imposed by the impact of 13
years of ivermectin treatment on parasite transmission and hence on effective population size.
If this interpretation is correct, the striking similarity between MBM07 and NKA07 is coinci-
dental: genetic drift is a stochastic process, and previously distinct populations may become
more similar by chance alone.
Alternatively, the similarity between NKA07 and MBM07 may indicate that there is trans-
mission between NKA07 and MBM07, such that as ivermectin shrank the originally naïve
MBM94 population over 13 years, exchange of parasites between the Nkam and the Mbam val-
leys mediated by vector or human migration brought these two initially dissimilar populations
closer together genetically. While the Nkam valley had not received CDTI at the time the
NKA07 samples were collected (the samples genotyped are classified as NLT, having only been
exposed to a single experimentally controlled round of ivermectin treatment [37]), some com-
munities in the Nkam valley are only ~10 km from communities across the Nkam river which
have received annual CDTI for >10 years. Consequently, the NKA07 parasites may not be
entirely naïve. However, transmission of multiply-exposed parasites from these villages into
NKA07 patients is unlikely to account for the similarities between NKA07 and MBM07, as the
NKA07 population was largely composed of GR parasites (94.3%, n = 140).
Our data do not allow discrimination between these two hypotheses. In either case, the
Cameroon data underline how little is known about the determinants of O. volvulus popula-
tion structure in general, and the genetic impact of population bottlenecks imposed by iver-
mectin-mediated temporary interruption and long-term reduction of transmission in O.
volvulus. These data also illustrate the confounding effect of underlying population structure
on our ability to distinguish between selection and drift as drivers of genetic differentiation
between two population samples, regardless of the origin of that structure, whether due to a
drug-induced population bottleneck, natural drift over time, or parasite immigration from a
drug-naïve into a drug-treated population.
Analysis of the distribution of response phenotypes revealed no clear separation of GR
(green) from SOR (red) in either Ghana or Cameroon samples (Fig 4C). Careful comparison
of Fig 4B and 4C (and reference to Table G in S1 Text) show that the Cameroon NKA07 para-
site group in Fig 4B (pink dots) is composed almost entirely of GR worms (SOR frequency of
approximately 5%, n = 140), whereas the MBM07 parasite group (Fig 4B, red dots) is com-
posed of a mix of GR worms (Fig 4C, green dots) and SOR worms (Fig 4C, red dots; SOR fre-
quency approximately 16% [n = 112]), but that the GR and SOR worms in both NKA07 and
MBM07 are intermingled, i.e. the differentiation between (NKA07 + MBM07) and MBM94 in
Fig 4B is unrelated to the distribution of drug phenotypes in Fig 4C. Thus, these data suggest
that genetic differentiation between the Cameroon populations is not correlated with response
phenotype.
To characterise further the differences between GR and SOR parasites within each country,
we analysed genotype frequencies for Hardy-Weinberg equilibrium (HWE). A greater number
of SNPs were significantly out of equilibrium in the GR populations compared to the SOR
populations from both countries (significance threshold of p< 0.05; 111 vs. 20 (of 131) SNPs
in the Cameroon GR vs. SOR parasites, S8 Table; and 80 vs. 68 (of 121) SNPs in the Ghana GR
vs. SOR parasites, S9 Table). In this respect, the Sequenom genotype and the whole genome
PoolSeq data are concordant: greater deviation from HWE in the GR populations is best
explained by ivermectin treatment reducing effective population size and genetic diversity and
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increasing genetic drift in the GR worms, but not in the SOR worms or ivermectin-naïve
populations.
Collectively, these Sequenom data suggest that spatial (between Ghana and Cameroon) and
temporal (pre- and post-13 years of drug exposure within Cameroon) genetic differentiation
was readily detectable by genotyping at these 130 SNP loci, but that this genotyping failed to
detect the relatively weaker signal of genetic differentiation between GR and SOR phenotypes.
This is illustrated most clearly by comparison of the Ghanaian and Cameroon SOR popula-
tions (Fig 4C), where the MDS coordinates of Ghanaian SOR individuals cluster with the Gha-
naian GR individuals, and Cameroon SOR individuals cluster with Cameroon GR, evidence
that SOR alleles exist in genetic backgrounds determined by their population of origin, and
that the genetic signature of soft selection for SOR in different naïve populations is weak com-
pared to the pre-existing population structure that is the product of genetic drift. This is fur-
ther supported by an analysis of genotype-based assignment of individual parasites to their
respective populations (Table K and Fig C of S1 Text). Greater that 99.5% of individuals were
correctly assigned to their country of origin by their genotype, and between 40–92.4% of indi-
viduals from Cameroon and 0–97% of individuals from Ghana to their respective communities
or regions. In contrast, 0% of Cameroon worms and only 8.1% of Ghanaian worms were cor-
rectly assigned as SOR worms on the basis of their genotypes, i.e., there is strong correlation
between Sequenom genotype and place of origin but little or no correlation between Seque-
nom genotype and ivermectin response phenotype. Furthermore, the MDS analysis of the
three Cameroon groups of samples (Fig 4C) supports the view that not only do past histories
of geographical or ecological separation result in genetic drift and hence differentiation
between O. volvulus populations, but that reduction or interruption of transmission and reduc-
tion in population size by ivermectin treatment, and/or migration from untreated into treated
populations also drives drift and masks selection.
Implications for control and elimination
The success of CDTI in the majority of areas in Africa where CDTI has been implemented
with good coverage [17], suggests that the alleles responsible for SOR are not common across
Africa and that CDTI can interrupt transmission in many populations. This success is clearly
dependent on epidemiological and programmatic factors such as the intensity of blackfly bit-
ing on humans and the frequency and achieved coverage of and adherence to CDTI [28, 33,
106–108]. However, it is also clear that drug response by O. volvulus is not uniform in all iver-
mectin-naïve populations [5, 27, 37, 46, 47], and that in some naïve populations (such as those
sampled here), parasites with sub-optimal response to ivermectin’s anti-fecundity effect are
present prior to ivermectin treatment. The data presented here provide an explanation for the
presence of SOR worms in ivermectin-naïve populations, and support the view that SOR to
ivermectin in those populations is a genetically determined trait that can increase in frequency
as a result of selection. Selection for SOR has progressed to an extent in the populations sam-
pled for analysis here, as the genetic signal of that selection can be detected in the Pool-seq
data. The genetic signal is, however, weak because it is based on soft selection acting on many
genes that contribute to a QT. The implications of these conclusions for control and elimina-
tion hinge on three crucial questions.
The first question is whether, and under what circumstances, SOR can be detected geneti-
cally. The whole genome Pool-seq data demonstrate that it is possible to detect SOR genotypes
in an analysis of 248,102 SNPs but our first attempt to validate SOR alleles in individual worms
by reducing the number of SNP’s to a panel 130 SNPs in Sequenom genotyping failed. This
failure is likely due to soft selection for SOR leaving a faint genetic signature in the SOR
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populations compared to the very strong, pre-existing population structure signals and proba-
ble ivermectin-induced genetic drift in treated populations. More careful marker selection
based on better quality whole genome sequence data from individual- rather than pooled-
worms may solve this problem and permit sensitive detection of SOR genotypes in samples
drawn from a single parasite population, i.e., transmission zone.
The second crucial question is whether it is possible to predict the likelihood that SOR fre-
quency will increase to a level that prevents elimination of O. volvulus transmission in a given
population. Our data suggest that ivermectin reduces the population size of GR worms, as one
would expect, but that the population of SOR worms is stable and/or increasing as the GR pop-
ulation shrinks. In very simple terms it is, therefore, a race: will the rate of population contrac-
tion (driven by the temporary interruption and long-term reduction of transmission of GR
worms) outpace the rate at which the SOR population stabilises and expands (because they
continue to be transmitted). If GR decline is faster than SOR expansion and the parasite popu-
lation declines below the transmission breakpoint, local elimination will occur. If expansion of
the SOR population prevents the parasite population declining below that threshold, transmis-
sion will persist, prevalence of infection will rebound and elimination will not occur. The out-
come of the race will be determined by: (i) the starting frequency of SOR in a naïve population
when ivermectin treatment begins, (ii) the relative rates of GR population contraction and
SOR population expansion, and (iii) the population size at which transmission is no longer
sustainable (the threshold for maintenance of transmission or transmission breakpoint).
Developing genotyping assays that can measure the pre-treatment (or current) SOR frequency
and monitor the relative rates of GR contraction and SOR stabilisation/expansion (the two
critical parameters identified above) in populations undergoing CDTI is therefore essential to
detect populations in which elimination may prove problematic. Furthermore, the response
phenotypes in terms of the dynamics of microfilarial production and reappearance in the skin
[36], and thus availability of skin microfilariae for vectors to ingest need to be better under-
stood. They could then be taken into account for timing CDTI relative to vector abundance so
that the ratio of progeny of SOR/progeny of GR is minimal when the availability of vectors is
maximal.
The third crucial question is whether SOR is likely to spread from one location to another.
The analysis of population structure suggests that all of the communities sampled in Ghana
are in a single transmission zone (there is no internal population structure between the Ghana-
ian communities), so that SOR could be transmitted between communities in this region of
Ghana. This is also likely to be true for the regions sampled in Cameroon. The tentative con-
clusion from analysis of the Sequenom data for MBM94, MBM07 and NKA07 from Cameroon
suggests that immigration from an area not under CDTI (Nkam valley) into a population
under CDTI may occur (suggested by the similarity between MBM07 and NKA07), even if the
pre-treatment level of transmission between the two populations is low (as is suggested by
comparison of NKA07 and MBM94, which are genetically distinct populations). While the
concept of recrudescence in areas undergoing control as a result of immigration from neigh-
bouring regions with less or no control is not new, these data provide the first genetic evidence
that such immigration has likely occurred. In contrast, Ghana and Cameroon are clearly sepa-
rated genetically, which implies there is no transmission of O. volvulus at this scale and SOR
will not spread from Ghana to Cameroon (or vice versa). While this is not surprising given the
location and distance between the two countries; the data show that genetic markers were able
to detect transmission between endemic areas within Cameroon and Ghana (i.e. are transmis-
sion zone markers) and thus could be a useful tool for onchocerciasis control programmes.
Such a tool could support decisions on whether to stop CDTI when criteria for stopping CDTI
have been met in one area but not in others in a geographical context that makes transmission
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between these two areas possible. These data also suggest that not only can genetic markers
sensitively detect transmission between geographic locations, but also that QLTs associated
with SOR could increase in frequency in neighbouring regions having little drug selection
pressure as a result of transmission.
With respect to SORs, genotyping assays will benefit control programmes in multiple ways
by (i) providing diagnostic tools to monitor changes in the frequency of SORs (non-invasive
through genotyping infective larvae in the vector [109]), (ii) discriminating between genetic
explanations for persistence of transmission (i.e., presence/selection for SOR) and other factors
that determine CDTI success (such as host-related factors, treatment coverage and compli-
ance, pre-control prevalence and intensity of infection and vector biting rates [48–53, 107]),
(iii) suggesting a trigger for the initiation of alternative treatment strategies, such as anti-Wol-
bachia treatment [110, 111], local vector control, new treatments that may become available
such as moxidectin [46, 112], combinations of interventions, or novel macrofilaricides (as
reviewed in [113]) in populations where persistent transmission is observed despite prolonged
CDTI [114].
Conclusions
The data presented suggest that the evolution of SOR to ivermectin in O. volvulus is via soft
selective sweeps of pre-existing QTLs rather than via a hard selective sweep of a relatively rare
resistance-conferring mutation. The outcome of this soft selection is the accumulation of
many alleles in a limited number of functional pathways that facilitate the recovery of adult
female worm fecundity from the inhibitory effects of ivermectin. This is consistent with the
observation that the acute microfilaricidal and macrofilarial anti-fecundity effects of ivermec-
tin remain unaltered in SOR populations, but that the difference between SOR and GR para-
sites is quantitative variation in the rate and extent to which microfilarial production is
resumed after ivermectin treatment. This conclusion (of a soft selective sweep of quantitative
variation in the rate of recovery from the effects of ivermectin) is based on the presence of mul-
tiple, geographically independent genetic signals throughout the genome that differentiate GR
and SOR pools and the apparent preservation of genetic diversity within the SOR populations
following selection. Furthermore, when these data are considered together with the population
bottlenecks that characterise the transmission of O. volvulus through its lifecycle and the likeli-
hood of some degree of inbreeding, we conclude that O. volvulus populations are variable and
can be structured due to allele frequency change in the absence of selection, i.e., as a conse-
quence of genetic drift. What is unclear is the extent to which each putative QTL contributes
to the development of SOR. The failure of the single worm genotyping using a panel of 130
SNPs to define more precisely a region of the genome associated with SOR does suggest that
the signature of selection in these populations is subtle and that no single putative QTL domi-
nates the response; further validation of the putative QTLs is clearly required. A more thor-
ough association analysis of each genomic region with SOR may be achieved by additional
whole genome sequencing using single adult worms (as opposed to pool sequencing as
described here) together with a more precise estimation of the ivermectin response of the indi-
vidual worm. This would allow fine mapping of QTLs, and estimation of their effect size and
penetrance, and ultimately, of the heritability of SOR. Such analyses should take transmission
zones and population stratification into account to determine the extent of gene flow and
therefore, the ability of SOR alleles to be transmitted within and between populations. Addi-
tional sequencing of individual parasites may also provide greater confidence in assigning
genetic associations to individual SNPs, opening the way to investigation of the likely function
of individual SNPs as putative SOR-conferring variants. Given the increasing accessibility of
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genomic resources, the reduced cost of next-generation sequencing, and the ability to look at
the whole genome in an unbiased way, we propose that genome-wide analyses such as those
applied here should replace candidate gene approaches for future work concerned with the
genetics and diagnosis of drug resistance in helminth parasites.
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